| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
1992-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82087fc0bc68789604aa1998de9727dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b42b0e4ee2bee416f0fc4b28d256915 |
| publicationDate |
1993-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H05238934-A |
| titleOfInvention |
Anxiolytic |
| abstract |
(57) [Summary] [Purpose] Effective in suppressing anxiety either due to unexplained general anxiety disorders, or especially caused or exacerbated by the process of withdrawal from benzodiazepine compounds. Provide anxiolytics. [Structure] 4- [4- (5-fluoro-2-pyrimidinyl) -1-piperazinyl] -1- (4-fluorophenyl) butanol or, preferably, its (R)-(+)-enantiomer or its Includes pharmaceutically acceptable acid addition salts and / or hydrates. |
| priorityDate |
1991-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |